Cardiac Surgery Devices Market Outlook (2022 to 2032)

The global cardiac surgery devices market is expected to enjoy a valuation of US$ 1.7 Billion by the end of 2022 and further expand at a CAGR of 3.6% during the forecast period (2022 to 2032). Sales in the market are expected to reach a valuation of ~US$ 2.4 Billion by 2032 on the back of the rising prevalence of cardiovascular diseases. In terms of product type, the perfusion disposables led the market with a demand share of about 59.1%% in 2021.

Cardiac surgery devices are devices used during an open heart procedure to repair structural defects in the cardiovascular system, such as coronary artery bypass grafting, congenital heart defects, abdominal aortic aneurysm repair, ventricular remodeling, and implantation of cardiac assist devices. Devices such as heart-lung machines are used during cardiothoracic surgery and are most commonly used to perform a cardiopulmonary bypass.

Attributes Key Insights
Cardiac Surgery Devices Market Value 2021 US$ 1.6 Billion
Estimated Market Size 2022 US$ 1.7 Billion
Projected Market Value 2032 US$ 2.4 Billion
CAGR 2022 to 2032 3.6%
Market Share of Top 5 Countries 57.6%

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

Sales Analysis of Cardiac Surgery Devices from 2012 to 2021 Vs Demand Outlook for 2022 to 2032

As per Future Market Insights (FMI), the demand in the global cardiac surgery devices market grew at a CAGR of 3.2% from 2012 to 2021. Sales in the market are poised to expand owing to the rising demand for coronary artery treatment and rising technological advancements in the healthcare industry.

The cardiac surgery devices market was approximately 1% of the global medical device market valued at US$ 457 Billion in 2021. Devices for cardiac surgery are being developed as per patients' needs and on the back of technological advancements in the industry. Hence, key players in the cardiac surgery devices market are launching cutting-edge technologies and designs to strengthen their position in the industry.

Furthermore, there is an increased demand for cardiac surgical equipment due to the rising incidence of cardiovascular diseases, especially among the older population. For instance, it is anticipated that by 2060, 98 million Americans aged 65 and older will be more than a fourfold increase from the current 46 million. The World Health Organization (WHO) report states that cardiovascular disease is the top cause of death worldwide. About 17.9 million deaths globally in 2019 were attributed to cardiovascular illnesses, i.e., 32% of all fatalities.

Further, demand for effective cardiac surgery devices, accessories, and surgical procedures will be fuelled as leading healthcare companies are expanding their cardiovascular devices product portfolio. These companies are also likely to form alliances and acquire companies to generate efficient product advancements that are safe and effective. On the back of these aforementioned factors, the global cardiac surgery devices market is expected to grow at a CAGR of 3.6% during the forecast period from 2022 to 2032.

Cardiac Surgery Devices Market

What are the Key Opportunities for the Cardiac Surgery Device Manufacturers?

Favorable Government Investments and Product Launches to be the Key Strategy for Growth

Government authorities in developing countries have been promoting start-up businesses and MNCs to help the healthcare and medical device industries grow commercially. To strengthen their position, leading firms in the medical device industry are collaborating with the government. Hence, with increasing government funding and initiatives in countries such as India, China, and Japan, the cardiac surgery devices market is expected to flourish over the upcoming decade.

Furthermore, the increasing prevalence of chronic diseases and rising traumatic injuries in developing economies is expected to propel growth over the forecast period. Moreover, manufacturers are consistently improving their product portfolio by developing novel and efficient products. Hence, the advent of technologically advanced devices and increased product launches will drive the cardiac surgery devices market.

Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Which are the Factors Restraining Demand for Cardiac Surgery Devices?

Stringent Regulations and High Cost of Cardiac Surgery Devices to Impede the Growth

The demand for cardiac surgery devices is likely to be restrained due to high pricing and cost-cutting for cardiac surgery device manufacturers. The pricing pressure due to government regulations and competitive pricing on healthcare device manufacturers might create challenges for incumbents and start-ups in developing economies.

Moreover, the cardiac surgery devices market can be negatively affected due to strict and extended approval processes by regulatory authorities such as the FDA and others. Cardiac surgery instruments such as heart-lung machines and heat exchangers are known as class II medical equipment in the USA. FDA.

Therefore, these instruments undergo a special test for their compatibility, performance, sterility, and shelf life. Thus, these devices need to obtain regulatory approval, which is an expensive and lengthy process. This is expected to impede the overall growth in the cardiac surgery devices market.

Country-wise Insights

How will Demand in the USA Cardiac Surgery Devices Market Surge?

Rising Cases of Obesity and Cardiovascular Diseases to Boost the Sales

The USA dominated the North American cardiac surgery devices market with a total share of about 86.2% in 2021. Demand in the market is predicted to rise on the back of rising cardiovascular diseases in the country. With the growing prevalence of obesity in the USA a significant share of the population suffers from cardiovascular diseases.

Among these, a considerable percentage of the population undergoes cardiac surgery, as per the study. Backed by this, the demand for advanced cardiac surgery devices is expected to increase over the forecast period.

Additionally, another key factor such as rising healthcare costs is contributing to the USA. cardiac surgery devices market. For instance, in the USA heart disease is the leading cause of death for both genders and for individuals of the majority of racial and ethnic groups. The deaths caused by heart disorders were almost 697,000 people in 2020, according to the report by the Centers for Disease Control and Prevention.

What is the Outlook for India in the Cardiac Surgery Devices Market?

Cost-Effective Treatment Rates in India to Propel Cardiac Surgery Devices Sales

India is set to exhibit growth at a CAGR of nearly 2.7% in the South Asia cardiac surgery devices market during the forecast period. An increasing number of patients undergoing cardiac surgeries is expected to positively affect sales in India. Due to the rising incidence of cardiac conditions, treatment rates are also surging. This is expected to improve the growth in the cardiac surgery devices market.

As per the study in BMJ Journals, approximately 60,000 open heart surgeries are performed annually in India. Therefore, the increasing number of heart bypass surgeries, heart valve surgeries, and heart transplant surgeries are propelling the market for cardiac surgery devices in India.

In India, the cost of surgeries and treatments is comparatively less than in other countries like USA and Europe. Thus, the increasing popularity of medical tourism in India is propelling growth in the market.

Will Germany Emerge as a Lucrative Cardiac Surgery Devices Market?

Growing Medical Tourism in Germany to Aid the Growth in Cardiac Surgery Devices Market

Germany held approximately a 4.1% share in the global cardiac surgery devices market in 2021 and is projected to display a growth rate of 4.9 % during the forecast period.

The developing healthcare infrastructure and increasing medical tourism in Germany are the key factors propelling the demand for cardiac surgery devices. Germany is one of the countries leading the medical tourism field due to the high international standards and technological advancements such as robotic surgery.

Further, hospitals in Germany are adopting high-quality medical equipment to treat different heart surgeries. Therefore, the technological advancements in cardiac surgery devices are driving growth in Germany.

Get the data you need at a Fraction of the cost

Personalize your report by choosing insights you need
and save 40%!

Category-wise Insights

Which Type of Product is Gaining Traction in Cardiac Surgery Devices Market?

Over 3/5th of Cardiac Surgery Devices, Sales are to be Contributed by Perfusion Disposables

In terms of product type, perfusion disposables held a share of approximately 59.1% in 2021. Growth in the segment is expected to surge as cases of valvular degeneration in the geriatric population rise. Additionally, the extensively developed healthcare industry and advancements in cardiac surgery devices are also accelerating the growth in the segment.

Which Type of Procedure will Generate the Maximum Profit in Cardiac Surgery Devices Market?

Rising Incidence of Coronary Heart Diseases to Propel the Adoption in the Market

Based on the procedure, the coronary artery bypass grafting segment accounted for 61.6% of the sales in the global cardiac surgery devices market. The frequency of cardiovascular conditions like coronary heart disease (CHD), peripheral vascular disease, etc. is increasing globally. Hence, the use of coronary artery bypass grafting surgical procedures is expected to surge to treat cardiovascular disorders.

Which is the Leading End User in the Cardiac Surgery Devices Market?

In terms of end users, the hospital's segment held the highest market share of around 60.1% in 2021. In hospitals, the adoption of cardiac treatment and surgeries is benefiting the market growth. The hospitals are improving the quality of treatment and customer service with cost reduction. The hospitals are ahead of the curve in identifying favorable avenues to improve healthcare delivery.

Competitive Landscape

In the cardiac surgery devices market, manufacturers are adopting different strategies to raise their sales and gain revenue. Leading firms are implementing activities like advanced product launches and acquisitions to expand their product portfolio. A few of these strategies undertaken by cardiac surgery devices manufacturers are:

  • On August 2022, the acquisition of Affera, Inc. has been completed, according to the announcement from Medtronic plc, a pioneer in healthcare technology worldwide. With this acquisition, the company's offering for cardiac ablation is expanded to include its first-ever cardiac mapping and navigation platform, which combines a radiofrequency ablation solution with a targeted pulsed field and distinct diagnostic technology.
  • On June 2020, the launch of DIRECTSENSE technology was declared by Boston Scientific in the USA It is a tool that is used for monitoring the effect of radiofrequency energy during the process of cardiac ablation.

Report Scope as per Cardiac Surgery Devices Market Analysis

Attribute Details
Estimated Market Size 2022 US$ 1.7 Billion
Projected Market Value 2032 US$ 2.4 Billion
CAGR 2022 to 2032 3.6%
Forecast Period 2022 to 2032
Historical Data Available for 2012 to 2021
Market Analysis US$ Million for Value
Key Regions Covered North America, Latin America, Europe, South Asia, East Asia, Oceania, and Middle East & Africa
Key Countries Covered USA, Canada, Brazil, Mexico, Argentina, United Kingdom, Germany, Italy, Russia, Spain, France, BENELUX, Nordic Countries, India, Thailand, Indonesia, Malaysia, Japan, China, South Korea, Australia, New Zealand, Turkey, GCC Countries, and South Africa
Key Market Segments Covered Product, Procedure, End User, and Region
Key Companies Profiled
  • Abbott Laboratories
  • Medtronic Plc.
  • Boston Scientific Corporation
  • Lepu Medical Technology Co ltd
  • LivaNova PLC
  • Terumo Corporation
  • Getinge-Maquet Germany Holding GmbH
  • B. Braun Melsungen AG
  • C. R. Bard, Inc
  • Teleflex Incorporated
  • Angiodynamics
  • Edwards Lifesciences Corporation
  • MicroPort Scientific Corporation,
  • Smith Medical
  • Abiomed, Inc
  • Estech
  • Cook Medical Inc
  • Braile Biomedica
  • Biotronik Inc.

Key Market Segments Covered in Cardiac Surgery Devices Market Research

By Product:

  • Heart Lung Machine
  • Breathing Heart Surgery Systems
    • Stabilizers
    • Positioners
  • Catheters
    • Ablation Catheter
    • Drainage Catheter
  • Perfusion Disposables
    • Oxygenators
    • Centrifugal Pumps
    • Cardioplegia Delivery System

By Procedure:

  • Coronary Artery Bypass Grafting
    • On Pump CABG
    • Off-Pump CABG
  • Minimally Invasive Surgery

By End User:

  • Hospitals
  • Ambulatory Surgical Centres

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East and Africa (MEA)

Frequently Asked Questions

How much is the cardiac surgery devices market worth in 2021?

The global cardiac surgery devices market is worth US$ 1.6 Billion in 2021.

What is the sales forecast for the cardiac surgery devices market through 2032?

The cardiac surgery devices market is expected to reach US$ 2.Billion Bn by the end of 2032, with sales expected to register a 3.6% CAGR over the forecast period (2022 to 2032).

What are the key trends shaping the cardiac surgery devices industry?

Rising cases of heart diseases, increasing demand for large coronary artery treatment, and strategic collaborations among key players are the key trends shaping the cardiac surgery devices industry.

Which are the top five countries driving demand in cardiac surgery devices market?

The USA., Japan, Canada, China, and Germany are the top five countries driving the demand for cardiac surgery devices.

What is the demand outlook in North America cardiac surgery devices market?

The North American cardiac surgery devices market registered a market share of around 40.2 % in the year 2021.

How will demand in Japan cardiac surgery devices market unfold?

The Japan cardiac surgery devices market is expected to register a growth rate of 2.7% CAGR in the forecast period.

Which countries are the key producers of cardiac surgery devices?

The USA, Japan, and China are the key producers in the cardiac surgery devices market.

How much is the India cardiac surgery devices market worth in 2021?

The India cardiac surgery devices market is worth US$ 56.4 Million in 2021.

What is the outlook of the United Kingdom cardiac surgery devices market?

The United Kingdom cardiac surgery devices market is to grow with a growth rate of 55 over the forecast period.

Table of Content
1. Executive Summary | Cardiac Surgery Devices Market
    1.1. Global Market Outlook
    1.2. Demand Side Trends
    1.3. Supply-Side Trends
    1.4. Analysis and Recommendations
2. Market Overview
    2.1. Market Coverage / Taxonomy
    2.2. Market Definition / Scope / Limitations
    2.3. Inclusions and Exclusions
3. Key Market Trends
    3.1. Key Trends Impacting the Market
    3.2. Development/Innovation Trends
4. Key Success Factors
    4.1. Product Features/ USPs Analysis
    4.2. Product Adoption / Usage Analysis
    4.3. Key Promotional Strategies, By Key Manufacturers
    4.4. Disease Epidemiology
    4.5. Regulatory Landscape
    4.6. PESTLE Analysis
    4.7. Porter’s Analysis
5. Market Background
    5.1. Macro-Economic Factors
        5.1.1. Global GDP Growth Outlook
        5.1.2. Global Healthcare Expenditure
        5.1.3. Global Medical Device Market Outlook
    5.2. Forecast Factors - Relevance & Impact
        5.2.1. Key Player’s Historic Growth
        5.2.2. Market Consolidation Activities
        5.2.3. New Product Launches / Approvals
        5.2.4. Increasing Rate of Cardiac Surgery
        5.2.5. Availability of Products
        5.2.6. Cost of Products
    5.3. Market Dynamics
        5.3.1. Drivers
        5.3.2. Restraints
        5.3.3. Opportunity Analysis
6. COVID-19 Crisis - Impact Assessment
    6.1. COVID-19 and Impact Analysis
        6.1.1. By Product
        6.1.2. By Procedure
        6.1.3. By End User
        6.1.4. By Region
    6.2. 2021 Market Scenario
7. Global Market Demand (in Value or Size in US$ Million) Analysis 2012 to 2021 and Forecast, 2022 to 2032
    7.1. Historical Market Value (US$ Million) Analysis, 2012 to 2021
    7.2. Current and Future Market Value (US$ Million) Projections, 2022 to 2032
        7.2.1. Y-o-Y Growth Trend Analysis
        7.2.2. Absolute $ Opportunity Analysis
8. Global Market Analysis 2012 to 2021 and Forecast 2022 to 2032, By Product
    8.1. Introduction / Key Findings
    8.2. Historical Market Size (US$ Million) Analysis By Product, 2012 to 2021
    8.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Product, 2022 to 2032
        8.3.1. Heart Lung Machine
        8.3.2. Breathing Heart Surgery Systems
            8.3.2.1. Stabilizers
            8.3.2.2. Positioners
        8.3.3. Catheters
            8.3.3.1. Ablation Catheter
            8.3.3.2. Drainage Catheter
        8.3.4. Perfusion Disposables
            8.3.4.1. Oxygenators
            8.3.4.2. Centrifugal Pumps
            8.3.4.3. Cardioplegia Delivery System
    8.4. Market Attractiveness Analysis By Product
9. Global Market Analysis 2012 to 2021 and Forecast 2022 to 2032, By Procedure
    9.1. Introduction / Key Findings
    9.2. Historical Market Size (US$ Million) By Procedure, 2012 to 2021
    9.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Procedure, 2022 to 2032
        9.3.1. Coronary Artery Bypass Grafting
            9.3.1.1. On Pump CABG
            9.3.1.2. Off Pump CABG
        9.3.2. Minimally Invasive Surgery
    9.4. Market Attractiveness Analysis By Procedure
10. Global Market Analysis 2012 to 2021 and Forecast 2022 to 2032, By End User
    10.1. Introduction / Key Findings
    10.2. Historical Market Size (US$ Million) By End User, 2012 to 2021
    10.3. Current and Future Market Size (US$ Million) Analysis and Forecast By End User, 2022 to 2032
        10.3.1. Hospitals
        10.3.2. Ambulatory Surgical Centers
    10.4. Market Attractiveness Analysis By End User
11. Global Market Analysis 2012 to 2021 and Forecast 2022 to 2032, By Region
    11.1. Introduction
    11.2. Historical Market Size (US$ Million) Analysis By Region, 2012 to 2021
    11.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Region, 2022 to 2032
                11.3.1. North America
                11.3.2. Latin America
                11.3.3. Europe
                11.3.4. East Asia
                11.3.5. South Asia
                11.3.6. Oceania
                11.3.7. Middle East and Africa (MEA)
    11.4. Market Attractiveness Analysis By Region
12. North America Market Analysis 2012 to 2021 and Forecast 2022 to 2032
    12.1. Introduction
    12.2. Historical Market Size (US$ Million) Trend Analysis by Market Taxonomy, 2012 to 2021
    12.3. Current and Future Market Size (US$ Million) Analysis and Forecast by Market Taxonomy, 2022 to 2032
        12.3.1. By Country
            12.3.1.1. USA
            12.3.1.2. Canada
        12.3.2. By Product
        12.3.3. By Procedure
        12.3.4. By End User
    12.4. Market Attractiveness Analysis
        12.4.1. By Country
        12.4.2. By Product
        12.4.3. By Procedure
        12.4.4. By End User
    12.5. Market Trends
    12.6. Key Market Participants - Intensity Mapping
    12.7. Drivers and Restraints - Impact Analysis
    12.8. Country-Level Analysis & Forecast
        12.8.1. USA Market Analysis
            12.8.1.1. Introduction
            12.8.1.2. Market Analysis and Forecast by Market Taxonomy
                12.8.1.2.1. By Product
                12.8.1.2.2. By Procedure
                12.8.1.2.3. By End User
        12.8.2. Canada Market Analysis
            12.8.2.1. Introduction
            12.8.2.2. Market Analysis and Forecast by Market Taxonomy
                12.8.2.2.1. By Product
                12.8.2.2.2. By Procedure
                12.8.2.2.3. By End User
13. Latin America Market Analysis 2012 to 2021 and Forecast 2022 to 2032
    13.1. Introduction
    13.2. Historical Market Size (US$ Million) Trend Analysis by Market Taxonomy, 2012 to 2021
    13.3. Current and Future Market Size (US$ Million) Analysis and Forecast by Market Taxonomy, 2022 to 2032
        13.3.1. By Country
            13.3.1.1. Mexico
            13.3.1.2. Brazil
            13.3.1.3. Argentina
            13.3.1.4. Rest of Latin America
        13.3.2. By Product
        13.3.3. By Procedure
        13.3.4. By End User
    13.4. Market Attractiveness Analysis
        13.4.1. By Country
        13.4.2. By Product
        13.4.3. By Procedure
        13.4.4. By End User
    13.5. Market Trends
    13.6. Key Market Participants - Intensity Mapping
    13.7. Drivers and Restraints - Impact Analysis
    13.8. Country-Level Analysis & Forecast
        13.8.1. Mexico Market Analysis
            13.8.1.1. Introduction
            13.8.1.2. Market Analysis and Forecast by Market Taxonomy
                13.8.1.2.1. By Product
                13.8.1.2.2. By Procedure
                13.8.1.2.3. By End User
        13.8.2. Brazil Market Analysis
            13.8.2.1. Introduction
            13.8.2.2. Market Analysis and Forecast by Market Taxonomy
                13.8.2.2.1. By Product
                13.8.2.2.2. By Procedure
                13.8.2.2.3. By End User
        13.8.3. Argentina Market Analysis
            13.8.3.1. Introduction
            13.8.3.2. Market Analysis and Forecast by Market Taxonomy
                13.8.3.2.1. By Product
                13.8.3.2.2. By Procedure
                13.8.3.2.3. By End User
14. Europe Market Analysis 2012 to 2021 and Forecast 2022 to 2032
    14.1. Introduction
    14.2. Historical Market Size (US$ Million) Trend Analysis by Market Taxonomy, 2012 to 2021
    14.3. Current and Future Market Size (US$ Million) Analysis and Forecast by Market Taxonomy, 2022 to 2032
        14.3.1. By Country
            14.3.1.1. Germany
            14.3.1.2. Italy
            14.3.1.3. France
            14.3.1.4. United Kingdom
            14.3.1.5. Spain
            14.3.1.6. BENELUX
            14.3.1.7. Nordic Countries
            14.3.1.8. Russia
            14.3.1.9. Rest of Europe
        14.3.2. By Product
        14.3.3. By Procedure
        14.3.4. By End User
    14.4. Market Attractiveness Analysis
        14.4.1. By Country
        14.4.2. By Product
        14.4.3. By Procedure
        14.4.4. By End User
    14.5. Market Trends
    14.6. Key Market Participants - Intensity Mapping
    14.7. Drivers and Restraints - Impact Analysis
    14.8. Country-Level Analysis & Forecast
        14.8.1. Germany Market Analysis
            14.8.1.1. Introduction
            14.8.1.2. Market Analysis and Forecast by Market Taxonomy
                14.8.1.2.1. By Product
                14.8.1.2.2. By Procedure
                14.8.1.2.3. By End User
        14.8.2. Italy Market Analysis
            14.8.2.1. Introduction
            14.8.2.2. Market Analysis and Forecast by Market Taxonomy
                14.8.2.2.1. By Product
                14.8.2.2.2. By Procedure
                14.8.2.2.3. By End User
        14.8.3. France Market Analysis
            14.8.3.1. Introduction
            14.8.3.2. Market Analysis and Forecast by Market Taxonomy
                14.8.3.2.1. By Product
                14.8.3.2.2. By Procedure
                14.8.3.2.3. By End User
        14.8.4. United Kingdom Market Analysis
            14.8.4.1. Introduction
            14.8.4.2. Market Analysis and Forecast by Market Taxonomy
                14.8.4.2.1. By Product
                14.8.4.2.2. By Procedure
                14.8.4.2.3. By End User
        14.8.5. Spain Market Analysis
            14.8.5.1. Introduction
            14.8.5.2. Market Analysis and Forecast by Market Taxonomy
                14.8.5.2.1. By Product
                14.8.5.2.2. By Procedure
                14.8.5.2.3. By End User
        14.8.6. BENELUX Market Analysis
            14.8.6.1. Introduction
            14.8.6.2. Market Analysis and Forecast by Market Taxonomy
                14.8.6.2.1. By Product
                14.8.6.2.2. By Procedure
                14.8.6.2.3. By End User
        14.8.7. Nordic Countries Market Analysis
            14.8.7.1. Introduction
            14.8.7.2. Market Analysis and Forecast by Market Taxonomy
                14.8.7.2.1. By Product
                14.8.7.2.2. By Procedure
                14.8.7.2.3. By End User
        14.8.8. Russia Market Analysis
            14.8.8.1. Introduction
            14.8.8.2. Market Analysis and Forecast by Market Taxonomy
                14.8.8.2.1. By Product
                14.8.8.2.2. By Procedure
                14.8.8.2.3. By End User
15. East Asia Market Analysis 2012 to 2021 and Forecast 2022 to 2032
    15.1. Introduction
    15.2. Historical Market Size (US$ Million) Trend Analysis by Market Taxonomy, 2012 to 2021
    15.3. Current and Future Market Size (US$ Million) Analysis and Forecast by Market Taxonomy, 2022 to 2032
        15.3.1. By Country
            15.3.1.1. China
            15.3.1.2. Japan
            15.3.1.3. South Korea
        15.3.2. By Product
        15.3.3. By Procedure
        15.3.4. By End User
    15.4. Market Attractiveness Analysis
        15.4.1. By Country
        15.4.2. By Product
        15.4.3. By Procedure
        15.4.4. By End User
    15.5. By End User Market Trends
    15.6. Key Market Participants - Intensity Mapping
    15.7. Drivers and Restraints - Impact Analysis
    15.8. Country-Level Analysis & Forecast
        15.8.1. China Market Analysis
            15.8.1.1. Introduction
            15.8.1.2. Market Analysis and Forecast by Market Taxonomy
                15.8.1.2.1. By Product
                15.8.1.2.2. By Procedure
                15.8.1.2.3. By End User
        15.8.2. Japan Market Analysis
            15.8.2.1. Introduction
            15.8.2.2. Market Analysis and Forecast by Market Taxonomy
                15.8.2.2.1. By Product
                15.8.2.2.2. By Procedure
                15.8.2.2.3. By End User
        15.8.3. South Korea Market Analysis
            15.8.3.1. Introduction
            15.8.3.2. Market Analysis and Forecast by Market Taxonomy
                15.8.3.2.1. By Product
                15.8.3.2.2. By Procedure
                15.8.3.2.3. By End User
16. South Asia Market Analysis 2012 to 2021 and Forecast 2022 to 2032
    16.1. Introduction
    16.2. Historical Market Size (US$ Million) Trend Analysis by Market Taxonomy, 2012 to 2021
    16.3. Current and Future Market Size (US$ Million) Analysis and Forecast by Market Taxonomy, 2022 to 2032
        16.3.1. By Country
            16.3.1.1. India
            16.3.1.2. Indonesia
            16.3.1.3. Malaysia
            16.3.1.4. Thailand
            16.3.1.5. Rest of South Asia
        16.3.2. By Product
        16.3.3. By Procedure
        16.3.4. By End User
    16.4. Market Attractiveness Analysis
        16.4.1. By Country
        16.4.2. By Product
        16.4.3. By Procedure
        16.4.4. By End User
    16.5. Market Trends
    16.6. Key Market Participants - Intensity Mapping
    16.7. Drivers and Restraints - Impact Analysis
    16.8. Country-Level Analysis & Forecast
        16.8.1. India Market Analysis
            16.8.1.1. Introduction
            16.8.1.2. Market Analysis and Forecast by Market Taxonomy
                16.8.1.2.1. By Product
                16.8.1.2.2. By Procedure
                16.8.1.2.3. By End User
        16.8.2. Indonesia Market Analysis
            16.8.2.1. Introduction
            16.8.2.2. Market Analysis and Forecast by Market Taxonomy
                16.8.2.2.1. By Product
                16.8.2.2.2. By Procedure
                16.8.2.2.3. By End User
        16.8.3. Malaysia Market Analysis
            16.8.3.1. Introduction
            16.8.3.2. Market Analysis and Forecast by Market Taxonomy
                16.8.3.2.1. By Product
                16.8.3.2.2. By Procedure
                16.8.3.2.3. By End User
        16.8.4. Thailand Market Analysis
            16.8.4.1. Introduction
            16.8.4.2. Market Analysis and Forecast by Market Taxonomy
                16.8.4.2.1. By Product
                16.8.4.2.2. By Procedure
                16.8.4.2.3. By End User
17. Oceania Market 2012 to 2021 and Forecast 2022-2032
    17.1. Introduction
    17.2. Historical Market Size (US$ Million) Trend Analysis by Market Taxonomy, 2012 to 2021
    17.3. Current and Future Market Size (US$ Million) Analysis and Forecast by Market Taxonomy, 2022 to 2032
        17.3.1. By Country
            17.3.1.1. Australia
            17.3.1.2. New Zealand
        17.3.2. By Product
        17.3.3. By Procedure
        17.3.4. By End User
    17.4. Market Attractiveness Analysis
        17.4.1. By Country
        17.4.2. By Product
        17.4.3. By Procedure
        17.4.4. By End User
    17.5. Market Trends
    17.6. Key Market Participants - Intensity Mapping
    17.7. Drivers and Restraints - Impact Analysis
    17.8. Country-Level Analysis & Forecast
        17.8.1. Australia Market Analysis
            17.8.1.1. Introduction
            17.8.1.2. Market Analysis and Forecast by Market Taxonomy
                17.8.1.2.1. By Product
                17.8.1.2.2. By Procedure
                17.8.1.2.3. By End User
        17.8.2. New Zealand Market Analysis
            17.8.2.1. Introduction
            17.8.2.2. Market Analysis and Forecast by Market Taxonomy
                17.8.2.2.1. By Product
                17.8.2.2.2. By Procedure
                17.8.2.2.3. By End User
18. Middle East and Africa (MEA) Market Analysis 2012 to 2021 and Forecast 2022 to 2032
    18.1. Introduction
    18.2. Historical Market Size (US$ Million) Trend Analysis by Market Taxonomy, 2012 to 2021
    18.3. Current and Future Market Size (US$ Million) Analysis and Forecast by Market Taxonomy, 2022 to 2032
        18.3.1. By Country
            18.3.1.1. GCC Countries
            18.3.1.2. Turkey
            18.3.1.3. South Africa
            18.3.1.4. Rest of the Middle East and Africa
        18.3.2. By Product
        18.3.3. By Procedure
        18.3.4. By End User
    18.4. Market Attractiveness Analysis
        18.4.1. By Country
        18.4.2. By Product
        18.4.3. By Procedure
        18.4.4. By End User
    18.5. Market Trends
    18.6. Key Market Participants - Intensity Mapping
    18.7. Drivers and Restraints - Impact Analysis
    18.8. Country-Level Analysis & Forecast
        18.8.1. GCC Countries Market Analysis
            18.8.1.1. Introduction
            18.8.1.2. Market Analysis and Forecast by Market Taxonomy
                18.8.1.2.1. By Product
                18.8.1.2.2. By Procedure
                18.8.1.2.3. By End User
        18.8.2. Turkey Market Analysis
            18.8.2.1. Introduction
            18.8.2.2. Market Analysis and Forecast by Market Taxonomy
                18.8.2.2.1. By Product
                18.8.2.2.2. By Procedure
                18.8.2.2.3. By End User
        18.8.3. South Africa Market Analysis
            18.8.3.1. Introduction
            18.8.3.2. Market Analysis and Forecast by Market Taxonomy
                18.8.3.2.1. By Product
                18.8.3.2.2. By Procedure
                18.8.3.2.3. By End User
19. Market Structure Analysis
    19.1. Market Analysis by Tier of Companies
    19.2. Market Share Analysis of Top Players (%)
    19.3. Market Presence Analysis
        19.3.1. By Regional Footprint of Players
        19.3.2. Product Footprint of Players
        19.3.3. Channel Footprint of Players
20. Competition Analysis
    20.1. Competition Dashboard
    20.2. Competition Benchmarking
    20.3. Competition Deep Dive
        20.3.1. Abbott Laboratories
            20.3.1.1. Overview
            20.3.1.2. Product Portfolio
            20.3.1.3. Key Financials
            20.3.1.4. SWOT Analysis
            20.3.1.5. Key Developments
            20.3.1.6. Sales Footprint
            20.3.1.7. Strategy Overview
                20.3.1.7.1. Marketing Strategy
                20.3.1.7.2. Product Strategy
                20.3.1.7.3. Channel Strategy
        20.3.2. Medtronic Plc.
            20.3.2.1. Overview
            20.3.2.2. Product Portfolio
            20.3.2.3. Key Financials
            20.3.2.4. SWOT Analysis
            20.3.2.5. Key Developments
            20.3.2.6. Sales Footprint
            20.3.2.7. Strategy Overview
                20.3.2.7.1. Marketing Strategy
                20.3.2.7.2. Product Strategy
                20.3.2.7.3. Channel Strategy
        20.3.3. Boston Scientific Corporation
            20.3.3.1. Overview
            20.3.3.2. Product Portfolio
            20.3.3.3. Key Financials
            20.3.3.4. SWOT Analysis
            20.3.3.5. Key Developments
            20.3.3.6. Sales Footprint
            20.3.3.7. Strategy Overview
                20.3.3.7.1. Marketing Strategy
                20.3.3.7.2. Product Strategy
                20.3.3.7.3. Channel Strategy
        20.3.4. Lepu Medical Technology Co ltd
            20.3.4.1. Overview
            20.3.4.2. Product Portfolio
            20.3.4.3. Key Financials
            20.3.4.4. SWOT Analysis
            20.3.4.5. Key Developments
            20.3.4.6. Sales Footprint
            20.3.4.7. Strategy Overview
                20.3.4.7.1. Marketing Strategy
                20.3.4.7.2. Product Strategy
                20.3.4.7.3. Channel Strategy
        20.3.5. LivaNova PLC
            20.3.5.1. Overview
            20.3.5.2. Product Portfolio
            20.3.5.3. Key Financials
            20.3.5.4. SWOT Analysis
            20.3.5.5. Key Developments
            20.3.5.6. Sales Footprint
            20.3.5.7. Strategy Overview
                20.3.5.7.1. Marketing Strategy
                20.3.5.7.2. Product Strategy
                20.3.5.7.3. Channel Strategy
        20.3.6. Terumo Corporation
            20.3.6.1. Overview
            20.3.6.2. Product Portfolio
            20.3.6.3. Key Financials
            20.3.6.4. SWOT Analysis
            20.3.6.5. Key Developments
            20.3.6.6. Sales Footprint
            20.3.6.7. Strategy Overview
                20.3.6.7.1. Marketing Strategy
                20.3.6.7.2. Product Strategy
                20.3.6.7.3. Channel Strategy
        20.3.7. Getinge-Maquet Germany Holding GmbH
            20.3.7.1. Overview
            20.3.7.2. Product Portfolio
            20.3.7.3. Key Financials
            20.3.7.4. SWOT Analysis
            20.3.7.5. Key Developments
            20.3.7.6. Sales Footprint
            20.3.7.7. Strategy Overview
                20.3.7.7.1. Marketing Strategy
                20.3.7.7.2. Product Strategy
                20.3.7.7.3. Channel Strategy
        20.3.8. B. Braun Melsungen AG
            20.3.8.1. Overview
            20.3.8.2. Product Portfolio
            20.3.8.3. Key Financials
            20.3.8.4. SWOT Analysis
            20.3.8.5. Key Developments
            20.3.8.6. Sales Footprint
            20.3.8.7. Strategy Overview
                20.3.8.7.1. Marketing Strategy
                20.3.8.7.2. Product Strategy
                20.3.8.7.3. Channel Strategy
        20.3.9. C. R. Bard, Inc
            20.3.9.1. Overview
            20.3.9.2. Product Portfolio
            20.3.9.3. Key Financials
            20.3.9.4. SWOT Analysis
            20.3.9.5. Key Developments
            20.3.9.6. Sales Footprint
            20.3.9.7. Strategy Overview
                20.3.9.7.1. Marketing Strategy
                20.3.9.7.2. Product Strategy
                20.3.9.7.3. Channel Strategy
        20.3.10. Teleflex Incorporated
            20.3.10.1. Overview
            20.3.10.2. Product Portfolio
            20.3.10.3. Key Financials
            20.3.10.4. SWOT Analysis
            20.3.10.5. Key Developments
            20.3.10.6. Sales Footprint
            20.3.10.7. Strategy Overview
                20.3.10.7.1. Marketing Strategy
                20.3.10.7.2. Product Strategy
                20.3.10.7.3. Channel Strategy
        20.3.11. Angiodynamics
            20.3.11.1. Overview
            20.3.11.2. Product Portfolio
            20.3.11.3. Key Financials
            20.3.11.4. SWOT Analysis
            20.3.11.5. Key Developments
            20.3.11.6. Sales Footprint
            20.3.11.7. Strategy Overview
                20.3.11.7.1. Marketing Strategy
                20.3.11.7.2. Product Strategy
                20.3.11.7.3. Channel Strategy
        20.3.12. Edwards Lifesciences Corporation
            20.3.12.1. Overview
            20.3.12.2. Product Portfolio
            20.3.12.3. Key Financials
            20.3.12.4. SWOT Analysis
            20.3.12.5. Key Developments
            20.3.12.6. Sales Footprint
            20.3.12.7. Strategy Overview
                20.3.12.7.1. Marketing Strategy
                20.3.12.7.2. Product Strategy
                20.3.12.7.3. Channel Strategy
        20.3.13. MicroPort Scientific Corporation
            20.3.13.1. Overview
            20.3.13.2. Product Portfolio
            20.3.13.3. Key Financials
            20.3.13.4. SWOT Analysis
            20.3.13.5. Key Developments
            20.3.13.6. Sales Footprint
            20.3.13.7. Strategy Overview
                20.3.13.7.1. Marketing Strategy
                20.3.13.7.2. Product Strategy
                20.3.13.7.3. Channel Strategy
        20.3.14. Smith Medical
            20.3.14.1. Overview
            20.3.14.2. Product Portfolio
            20.3.14.3. Key Financials
            20.3.14.4. SWOT Analysis
            20.3.14.5. Key Developments
            20.3.14.6. Sales Footprint
            20.3.14.7. Strategy Overview
                20.3.14.7.1. Marketing Strategy
                20.3.14.7.2. Product Strategy
                20.3.14.7.3. Channel Strategy
        20.3.15. Abiomed, Inc
            20.3.15.1. Overview
            20.3.15.2. Product Portfolio
            20.3.15.3. Key Financials
            20.3.15.4. SWOT Analysis
            20.3.15.5. Key Developments
            20.3.15.6. Sales Footprint
            20.3.15.7. Strategy Overview
                20.3.15.7.1. Marketing Strategy
                20.3.15.7.2. Product Strategy
                20.3.15.7.3. Channel Strategy
        20.3.16. Estech
            20.3.16.1. Overview
            20.3.16.2. Product Portfolio
            20.3.16.3. Key Financials
            20.3.16.4. SWOT Analysis
            20.3.16.5. Key Developments
            20.3.16.6. Sales Footprint
            20.3.16.7. Strategy Overview
                20.3.16.7.1. Marketing Strategy
                20.3.16.7.2. Product Strategy
                20.3.16.7.3. Channel Strategy
        20.3.17. Cook Medical Inc
            20.3.17.1. Overview
            20.3.17.2. Product Portfolio
            20.3.17.3. Key Financials
            20.3.17.4. SWOT Analysis
            20.3.17.5. Key Developments
            20.3.17.6. Sales Footprint
            20.3.17.7. Strategy Overview
                20.3.17.7.1. Marketing Strategy
                20.3.17.7.2. Product Strategy
                20.3.17.7.3. Channel Strategy
        20.3.18. Braile Biomedica
            20.3.18.1. Overview
            20.3.18.2. Product Portfolio
            20.3.18.3. Key Financials
            20.3.18.4. SWOT Analysis
            20.3.18.5. Key Developments
            20.3.18.6. Sales Footprint
            20.3.18.7. Strategy Overview
                20.3.18.7.1. Marketing Strategy
                20.3.18.7.2. Product Strategy
                20.3.18.7.3. Channel Strategy
            20.3.18.8. Biotronik Inc Overview
            20.3.18.9. Product Portfolio
            20.3.18.10. Key Financials
            20.3.18.11. SWOT Analysis
            20.3.18.12. Key Developments
            20.3.18.13. Sales Footprint
            20.3.18.14. Strategy Overview
                20.3.18.14.1. Marketing Strategy
                20.3.18.14.2. Product Strategy
                20.3.18.14.3. Channel Strategy
21. Assumptions and Acronyms Used
22. Research Methodology
Recommendations

Healthcare

Coronary Artery Bypass Graft Market

October 2023

REP-GB-1070

326 pages

Healthcare

Cardiac Assist Devices Market

June 2023

REP-GB-467

315 pages

Healthcare

Cardiac Rhythm Management Market

October 2022

REP-GB-602

250 pages

Explore Healthcare Insights

View Reports
Future Market Insights

Cardiac Surgery Devices Market

Schedule a Call